SCHEMBL731102

SCHEMBL731102

Cc1ccc(S(=O)(=O)O)cc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCOLN3 Q8TDD5 2/20 0.60
CRHBP P24387 1/20 0.60
CRHR2 Q13324 1/20 0.60
ALDH1A1 P00352 8/20 0.57
HPGD P15428 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
TSHR P16473 2/20 0.55
CYP3A4 P08684 1/20 0.55
RECQL P46063 1/20 0.55
MAPK1 P28482 1/20 0.54
L3MBTL1 Q9Y468 2/20 0.53
NSD2 O96028 1/20 0.53
GAA P10253 1/20 0.53
PLCG1 P19174 1/20 0.53
DNMT1 P26358 1/20 0.53
CASP6 P55212 1/20 0.53
HTT P42858 1/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9568275 0.98 MCOLN3 (0.59) MCOLN3CRHBPCRHR2ALDH1A1HPGD
SCHEMBL9568274 0.98 MCOLN3 (0.59) MCOLN3CRHBPCRHR2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL28777156 0.98 MCOLN3 (0.59) MCOLN3CRHBPCRHR2ALDH1A1HPGD
SCHEMBL11745892 0.85 TSHR (0.54) MCOLN3CRHBPCRHR2ALDH1A1HPGD
SCHEMBL11745901 0.85 TSHR (0.54) MCOLN3CRHBPCRHR2ALDH1A1HPGD
SCHEMBL10744526 0.84 MCOLN3 (0.50) MCOLN3CRHBPCRHR2ALDH1A1HPGD
Hydrogen Peroxide SCHEMBL28682950 0.84 TSHR (0.57) MCOLN3CRHBPCRHR2ALDH1A1TDP1
SCHEMBL29397077 0.83 MCOLN3 (0.58) MCOLN3CRHBPCRHR2ALDH1A1TSHR
SCHEMBL10700954 0.83 MCOLN3 (0.58) MCOLN3CRHBPCRHR2ALDH1A1TSHR
SCHEMBL994972 0.83 MCOLN3 (0.58) MCOLN3CRHBPCRHR2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102491906-B Synthetic method for 2-methyl-3-trifluoromethyl phenylamine QILU ANIMAL HEALTH PRODUCTS CO 2013-10-23 CN claimed
CN-102491906-A Synthetic method for 2-methyl-3-trifluoromethyl phenylamine QILU ANIMAL HEALTH PRODUCTS CO 2012-06-13 CN claimed
WO-2010099518-A2 METHOD FOR MANUFACTURE OF 2-OXOIMIDAZOLIDINES THESIS CHEMISTRY, LLC (US) 2010-09-02 WO claimed
EP-1548069-B1 Liquid formulations of direct dyes BASF SE (DE) 2010-08-04 EP claimed
US-7331998-B2 Liquid formulations of direct dyes BASF AKTIENGESELLSCHAFT (DE) 2008-02-19 US claimed
CN-100334255-C Method for applying a phosphate covering and use of metal parts thus phospated CHEMETALL GMBH (DE) 2007-08-29 CN claimed
US-20050132510-A1 Liquid formulations of direct dyes BASF AKIENGESELLSCHAFT (DE) 2005-06-23 US claimed
CN-1196669-C Method for producing substituted nitro benzoic acids by oxidation of corresponding nitro toluenes, nitro benzyl alcohols, esters and/or ethers BAYER AG (DE) 2005-04-13 CN claimed
EP-1274672-B1 METHOD FOR PRODUCING SUBSTITUTED NITRO BENZOIC ACIDS BY OXIDATION OF CORRESPONDING NITRO TOLUENES, NITRO BENZYL ALCOHOLS, ESTERS AND/OR ETHERS BAYER CHEMICALS AG (DE) 2004-03-03 EP claimed
US-20040039227-A1 Method for producing substituted nitro benzoic acids by oxidation of corresponding nitro toluenes, nitrol benzyl alcohols, esters and/or ethers LANXESS DEUTSCHLAND GMBH (DE) 2004-02-26 US claimed
EP-1016405-A2 Arylating medicaments Radopath Pharmaceuticals International Limited (GB) 2000-07-05 EP claimed
CN-1203886-A Method for producing hydrogen sulfide TANG PEISI (CN) 1999-01-06 CN claimed
EP-0700287-A1 ARYLATING MEDICAMENTS RADOPATH LIMITED (GB) 1996-03-13 EP claimed
EP-0460544-B1 Process for the preparation of sulphonated anthranilic acids BASF AG (DE) 1995-08-09 EP claimed
WO-1994027584-A2 ARYLATING MEDICAMENTS RADOPATH LIMITED (GB) 1994-12-08 WO claimed
EP-0380067-B1 IMPROVED METHOD OF LUBRICATING IRON AND STEEL BEFORE COLD WORKING HENKEL CORPORATION (US) 1993-05-26 EP claimed
US-5196573-A Process for the preparation of sulfonated anthranilic acids BASF AKTIENGESELLSCHAFT (DE) 1993-03-23 US claimed
US-5086128-A HIGH MOLECULAR WEIGHT ARYLENE SULPHIDE POLYMER MELT MIXED WITH AROMATIC NITRO COMPOUND BAYER AKTIENGESELLSCHAFT (DE) 1992-02-04 US claimed
EP-0380067-A1 Improved method of lubricating iron and steel before cold working HENKEL CORPORATION (US) 1990-08-01 EP claimed
US-4426291-A Solvent extraction of nitrated organic compounds from aqueous solutions BASF WYANDOTTE CORPORATION (US) 1984-01-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039227-A1 Method for producing substituted nitro benzoic acids by oxidation of corresponding nitro toluenes, nitrol benzyl alcohols, esters and/or ethers NOS2, NOS1, CYP2E1 MCOLN3 3645/4885CRHBP 2926/4885CRHR2 4404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.